Atria Investments’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-10,676
| Closed | -$94.7K | – | 2048 |
|
2025
Q1 | $94.7K | Buy |
+10,676
| New | +$94.7K | ﹤0.01% | 1875 |
|
2024
Q4 | – | Sell |
-11,414
| Closed | -$313K | – | 1938 |
|
2024
Q3 | $313K | Buy |
11,414
+581
| +5% | +$15.9K | ﹤0.01% | 1604 |
|
2024
Q2 | $265K | Buy |
+10,833
| New | +$265K | ﹤0.01% | 1661 |
|
2014
Q3 | – | Sell |
-53,944
| Closed | -$2.1M | – | 474 |
|
2014
Q2 | $2.1M | Buy |
+53,944
| New | +$2.1M | 0.21% | 96 |
|